The Clinical Features of Comorbid Pediatric Bipolar Disorder in Children with Autism Spectrum Disorder

• Published in: Journal of autism and developmental disorders Vol. 48; no. 8; pp. 2800 - 2808
• Main Authors: Sapmaz, Dicle, Baykal, Saliha, Akbaş, Seher
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.08.2018; Springer; Springer Nature B.V
• Subjects: Adolescents; Affective disorders; Aggression; Autism; Autism Spectrum Disorders; Autistic children; Behavior Problems; Behavior Rating Scales; Behavioral Science and Psychology; Bipolar disorder; Care and treatment; Check Lists; Checklists; Child and School Psychology; Children; Clinical Diagnosis; College Faculty; Comorbidity; Control Groups; Departments; Diagnosis; Elementary Secondary Education; Genetic Disorders; Health aspects; Intervention; Interviews; Mania; Matched Groups; Mental Disorders; Neurosciences; Nonverbal Communication; Original Paper; Parent Participation; Pediatrics; Pervasive Developmental Disorders; Psychiatry; Psychological Evaluation; Psychology; Public Health; Schizophrenia; Symptoms (Individual Disorders); Therapeutic applications; Therapy; Turkic Languages; Verbal Communication; Young Children; Comorbidity; Autism Spectrum Disorders; Pediatric Bipolar Disorders
• ISSN: 0162-3257; 1573-3432; 1573-3432
• DOI: 10.1007/s10803-018-3541-x

The aim of this study was to describe clinical features of PBD comorbidity in children with ASD. Forty children with ASD and PBD aged 6–18 years, and 40 age- and sex-matched ASD subjects with no affective episodes were included in the study. Autism Behavior CheckList, Abberant Behavior CheckList, and Young Mania Rating Scale-Parent Version were completed. This study shows that PBD comorbidity in children with ASD involves a highly episodic course, with manic episodes, subsyndromal symptoms and interepisodic periods commonly being described in the manic symptom profile of these children. These findings need to be repeated with large samples, together with controlled studies concerning therapeutic interventions directed toward PBD comorbidity in children with ASD.